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Introduction
Cellulose is a linear polysaccharide consisting of a chain of β (1-4) 
linked D-glucose units.1 Cellulose is the major component of wood 
and most natural fibers from vegetal kingdom. This natural polymer 
represents about a third of the plant tissues and can regenerate through 
photosynthesis.2 Although vegetable origin cellulose is widely applied 
at industrial level, the productive scale generates serious problems on 
ecosystems where the pulp mills mega industries known as “pasteras” 
are located.3 In emerging countries such as Argentina and Uruguay, 
the location of these “pasteras”, generates great concern. A report pre-
sented by Uruguay Republic University (UDELAR) on 2006, summa-
rizes the available scientific evidence about environmental impacts 
of the installation of pulp mills and the associated forestry model.4 
The report presents an analysis and studies of the effects of the fo-
rest crop on the ecosystem, benefits provided by the natural pastu-
res, and the effects generated by the liquid effluents of the pasteras 
at hierarchical levels (molecular, individual, population, community 
and ecosystem).4 Traditionally the Kraft method is used to obtain ve-
getable cellulose, the numerous processes that make up the method, 
where each one contributes its share in energy consumption, chemical 
compounds and pollution.5 Materials from bio-based resources have 
attracted immense research interest in recent years as a result of their 
very high potentials for fabricating several high-value products with 
low impact on the environment.6 Cellulose is also produced by some 
species of bacteria such as Pseudomonas fluorescens, Gluconaceto-
bacter xylinus, Gluconacetobacter hansenni among others. In recent 
years another route for the production of micro/nanofibers of cellulose 
has received great attention.7 This is the microbial synthesis of cellu-
lose in which specific bacteria synthesize cellulose microfibrils as a 
primary metabolite.8 Cellulose molecules are synthesized in the inte-
rior of the bacterial cell and spun out to form nanofibrils which then 
aggregate in the form of ribbonshaped microfibrils.9 During biosyn-
thesis of cellulose chains, van der Waals forces and hydrogen bonding 
between hydroxyl groups and oxygen of adjacent molecules promote 
parallel stacking of multiple cellulose chains forming elementary fi-
brils that further aggregate into larger microfibrils.10 Bacterial Cellu-
lose impart attractive combinations of biophysicochemical characte-
ristics such as biocompatibility, biodegradability, light weight, non-
-toxicity, stiffness, renewability, sustainability, optical transparency, 
low thermal expansion, adaptable surface chemistry, and improved 
mechanical properties.11 Potential applications include barrier films, 
flexible displays, antimicrobial films, biomedical implants, transpa-
rent films, pharmaceuticals and drug delivery systems.1,12‒14 One of the 
cellulose producer bacteria is Pseudomonas fluorescens.15 These bac-
teria present a convenient behavior as cellulose biofactorie. The spa-
ce for cellulose attachment is between air and liquid interface, which 
when colonized, provides bacteria with access to both the gaseous 
(e.g. oxygen) and liquid (e.g. nutrient) phases.16 All so, these attach-
ments facilitate its harvest from reactor surface, diminish handling 
errors and improve production recovery process. These main factors 
represent advantages thinking on scaling up process, but commercial 
growing media are expensive for industrial. Many authors previously 
reported the use of waste from other industries as a carbon source 
for the production of bacterial cellulose.17‒19 However these practi-
ces, although very interesting and useful, adds steps to the process of 
product purification. In previous works,20,21 our research team presen-
ted new growing media designed as a clean production experience by 
recovering residual bacterial cell, from our lines. The main objective 
of this work was to develop growth media for increase bacterial nano 
cellulose (BNC) production, characterized it as non-active pharma-
ceutical ingredient (NAPI), design an efficient quality control method 
by compared our NAPI whit commercial ones and presented a first 
prototype of a pharmaceutical product.
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Abstract
Materials from bio-based resources have attracted immense research interest in recent 
years as a result of their very high potentials for fabricating several high-value products 
with low impact on the environment. Cellulose produced by some bacteria has received 
great attention. Bacterial Nano Cellulose (BNC) imparts attractive combinations of 
biophysicochemical characteristics and improved mechanical properties. The aims of 
this work was to develop growth media for increase BNC production, characterize 
a non-active pharmaceutical ingredient (NAPI), design an efficient quality control 
method by FTIR and SEM by compared that NAPI with commercial ones and present 
a first prototype of a pharmaceutical product. LB and KB media were modified and 
BNC obtained had better quality respect its crystallinity and/or polymerization degree 
than the BNC from commercial media. Different extraction processes were proposed, 
in no case microbiological material remnants has been found. Films for controlled 
drugs release prototype were made and its physical properties such as water solubility, 
moisture content, swelling property, UV barrier capacity were evaluated. BNC films 
present an additional advantage, having lower UV permeability than films with 
cellulose of vegetal origin, adding potentialities to a patch design that protects the 
tissue and the Active Pharmaceutical Ingredients.
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Material and methods
Bacterial strains and culture conditions
A Pseudomonas fluorescens WS strain (wrinkly spreader) (do-
nated by PhD Andrew Spears, School of Science, Engineering and 
Technology, Abertay University) It was grown in LB broth (Britania-
‒C.A.B.A‒Argentina) and kept at 25ºC.
Culture media design
Commercial media were used as controls King B broth-(Britania-
-Buenos Aires-Argentina) and Luria Bertani broth (Britania-Buenos 
Aires-Argentina). PH was measured, by using a Lutron Germany PH-
meter. To obtain high value products and allow us to reduce produc-
tion cost, 11 culture media were designed. 
Pseudomonas fluorescens static cultivation and BNC 
obtention
Research team designed several processes seeking that increase 
productivity and accomplish our ambient responsibility purpose.21 Fi-
gure 1 shows our more efficient process cycle.
Figure 1 Clean production process flux diagram.
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For BNC production, static cultivation was used. All growing test 
were made on petri dishes with 20mL of fresh medium for 72h at 
28±1°C.22 For BNC production estimation, all cellulose pellicles were 
washing with distillate water to remove medium. BNC was centrifu-
ged 20min at 8000rpm. Then 1mL of NaOH 2% v/v was added and 
autoclaved 15min at 121ºC, these procedure is made for detach some 
bacterial cell which could by immerse on BNC. Then, films were wa-
shed with distilled water until neutralization.23
BNC physical characterization- dry weight
Dry weight was measured after drying the films at 70°C until cons-
tant weight. The results were reported as ‘production’ and expressed 
in weight of dry cellulose per liter of original medium (g/L).24
BNC Structure analysis and estimation of crystallinity 
index by FTIR spectroscopy
Cellulose characteristic bands were determinate at mid infrared re-
gion (4000cm-1-500cm-1). The BNC samples were processed in solid 
pills with KBr employing a Perkin-Elmer GX-1 spectrophotometer 
(Perkin-Elmer, Waltham, MA). The spectra were obtained for tripli-
cate with 64 scans and 4cm-1 of resolution. OMNIC software version 
8.0 (Thermo Fisher Scientific, Waltham, MA) was used for the spectra 
analysis. Each spectrum was subjected to a baseline correction and an 
automatic smoothing prior to its analysis. Also, the crystallinity index 
(CI) of the final products was calculated based on the ratios between 
the absorbance at pre-established frequencies CI1 (A143-1419/A897-
894) and CI2 (A1375/A2900).25‒27
Scanning electron microscopy (SEM)
The dried samples were coated with gold using a cathode ion co-
ater (sputter coater), and observed in a scanning electron microscope 
Zeiss Supra 55VP with field emission cannon operated at 3kV. The 
size of the cellulose particles was measured by the software of the 
equipment used.
Congo red tinction 
Congo red tinction was made for optic microscope observation by 
adding one more step to Gram technique. For this purpose, amyloid 
stain Congo red was used (Sigma Aldrich INC. St. Luis-USA), all 
process was developed as described on Sigma Aldrich kit by setting 
gram tinction and then Congo red tinction for 20min. Then, by using 
a microscope camera (Digital Imager Usb Celestron-Buenos Aires- 
Argentina) pictures of stain crystals were taken.
Comparative evaluation with samples of 
commercial cellulose excipient by using elec-
tron microscope and FTIR espectroscopy te-
chniques 
Commercial cellulose samples
Commercial Non Active Pharmaceutical Ingredient (NAPI) was 
donated for: Cellint SA (Santa Fe – Argentina) and Cicloquimica SAC 
(Buenos Aires – Argentina) compared with BC, for these purpose, 
3commercial products were tested microcristaline cellulose named 
Comprecel M101D+(MINGTAI chemical Co. Ltd. Bah-Der City, 
Taoyuan Hsien, Taiwan), PH-101-LD (Cellint-Avellaneda-Santa Fe-
-Argentina), PH-102-LD (Cellint-Avellaneda-Santa Fe- Argentina). 
FTIR espectroscopy 
The BNC obtained from design media based on King B and LB 
and the BNC obtained from the King B and LB controls were com-
pared with a commercial cellulose sample PH-101-LD taking as stan-
dard reference. Structure comparison was performed based on spectra 
obtained for each sample using FTIR spectroscopy. Spectra were pro-
cessing with the same methodology described for the quality control.
Scanning electron microscopy (SEM)
Commercial samples and biotechnology produced samples, where 
compared by SEM technique as previously described.
Film for controlled drugs release prototype 
and first physical tests to characterize it
Pre formulation design protocol
Table 5 shows composition of films and commercial controls. 
For the pharmaceutical design, four commercial products were used: 
commercial cellulose (6.1) and hidroxypropil methyl cellulose 4KM 
(Cicloquimica SAC -Buenos Aires Argentina). Filmogenic solutions 
were prepared using cold mechanical method described.25 According 
to the casting technique, for each formulation, 25mL of filmogenic so-
lution was poured onto rectangular acrylic plates (106.25cm 2 of area) 
to obtain a constant thickness of 100±10μm, followed by drying at 
37±1°C for 16h, in an oven with forced air circulation MiLaB Drying 
oven 101AB (Buenos Aires-Argentina). The filmogenic solution was 
degassed using a sonicator Cleanson (Buenos Aires-Argentina). After 
drying, all films were stored at a controlled relative humidity of 53% 
at 25±1°C for three days prior to testing. Since films have a hydrophi-
lic character, high moisture ambient was chosen in order to evaluate 
film performance in a typical tropical weather condition.26,27
Determination of physical properties
Water solubility
Water solubility was determined according to the method reported 
by Rubilar, et al.28 The initial dry matter content of each film was 
determined by drying to constant weight in an oven at 105ºC. Film 
disks (2cm diameter) were cut, weighed (Mi), and immersed in 50mL 
of water. After 24h of immersion at 20ºC with agitation (60rpm), the 
samples were taken out and dried to constant weight (Mf) in an oven 
at 105ºC, to determine the weight of dry matter that was not solu-
bilized in water. The solubility of each film was then determined as 
follows:
( ) ( ) ( )   %    /    100 1Solubility in water Wi Wf Wi x= −
Where WI is the initial mass and Wf is the final mass of the sam-
ple. Three replicates were obtained for each sample.
Moisture content
To determine the moisture content of films, about 50mg of film 
were dried at 105ºC during 24h (until the equilibrium weight was at-
tained). The weight loss of the sample was determined, and moisture 
content was calculated using the following equation.29
( ) ( ) ( )  %    /   100 2Moisture content Mwi Mwf Mwi x= −
Where Mwi and Mwf are the masses of initial and dried samples, 
respectively, Three replicates were obtained for each sample.
Swelling property
According to the method reported.29 the films were cut into a piece 
of 2.5X2.5cm in size and weighted in air-dried conditions (w1). They 
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were then immersed in deionized water (25 ºC) for 2 min. Wet sam-
ples were wiped with filter paper to remove excess liquid and weigh-
ted (w2).29 The amount of adsorbed water was calculated as:
( ) ( ) ( ) %   100 2  1  /  1 3Swelling w w w= −
Where w2 and w1 were the weights of the wet and the air dried 
samples, The measurement was repeated three times for each type of 
film, and an average was taken as the result.
Opacity measurement 
 Film specimen was cut into a rectangle piece and placed in a spec-
trophotometer test cell directly, and air was used as the reference. A 
spectrum of each film was recorded on an UV-Vis spectrophotome-
ter (Thermo Scientific Multi scan Go- Buenos Aires- Argentina). The 
area under the absorption curve from 400 to 800nm was recorded, and 
the opacity of film was calculated by the following equation:
( )  500 /  4Opacity A T=
Where A500 was the absorption at 500nm, and T is the film thi-
ckness (mm).30 The measurement was repeated three times for each 
type of film, and an average was taken as the result.
Statistical Analysis
Each treatment was conducted in triplicate and all experiments 
were repeated at least twice. The statistical significance of the evalua-
ted data was analyzed by one-way analysis of variance. Differences 
among the mean values were tested using the least significant diffe-
rence multiple range test. Values were considered significant when 
p<0.05, except when otherwise indicated.
Results and discussion
Productive activity is a fundamental column in country’s econo-
mic development, also is one of the main factors of unsustainability. 
One of the greatest advantages of pharmaceutical biotechnology is the 
versatility. Although its approach to the production of drugs opens a 
plethora of green and sustainable possibilities, the generation of was-
te continues to represent a problem on a smaller scale, but it can be 
brought to near zero. Waste production and natural resources consume 
diminishing sustainability and economic growth. We are seeking to 
improve our own process and to insert Clean Production in our pro-
duction lines. In previous work data from designed Clean Production 
protocol and growing media where reported.21
Table 1 shows media composition designed by replacing or ad-
ded carbon fonts. By using King B broth as control 8 enriched media 
were designed. Table 2 shows 3 media designed by using LB medium 
as control. In previous work media design and growth kinetics were 
reported when P. fluorecens residual cells were used, 3media were 
presented and named GS1 (Gonzalez Sesto) to GS321, we choose 
GS1 for these work, as these presented the best cellulose productivity. 
Also we design GS4, which is GS1 with glucose added seeking to 
improve cellulose production yield. As media where designed, clean 
production protocol were also designed and time and volume of non-
-renewable resources were significantly diminished as we presented 
on Figure 1.
Table 1 Media culture’s composition based on King’s B media. Media design composition E1 to E4. King’s B commercial media was used as reference. Trip: 
Triptein; BE: Beef extract; SP: Soya Peptone; Gluc: Glucose; Glic: Glicerol; R King B Medium: consumed culture media
Media Trip BP K2HPO4 K2SO4 MgSO4 SP NaCl CaCl2 Gluc Glic R King B medium
Kings B x x x x        
KB1 x x x x      x  
KB2 x x x x     x x  
KB3 x x x x     x   
KB4 x x x x       x
E1 x x  x x x x     
E2 x x  x x x x x    
E3 x x x x  x x     
E4 x x x x  x x x    
Table 2 Media culture’s composition on Luria-Bertani media Media design 
composition The Luria-Bertani commercial media was used as reference. YE, 
Yeast extract; BE, Beef extract; BP, Beef peptone; BRC, Bacterial residual cells; 
Gluc, Glucose
Media YE BP NaCl BRC Gluc
LB x x x   
L1 x x x  x
GS1*  x x x  
GS4*  x x x x
*Media design contains the same ingredients that LB broth but replacing 50% 
of proteins by BRC ‘
‘The best solvent is no solvent and if a solvent is needed then water 
is preferred’’.31 The use of water is environmentally favorable due to it 
is nontoxic and nonflammable nature, and it is economically available 
because of its low price and abundant reserves. However, water has 
the highest heat capacity among all materials. Intensive energy inputs 
associated with production using water make it a challenge towards 
the demand for energy-saving production. In the last decade, an exten-
sive effort has been made in attempt to search for solvent alternatives 
to overcome the environmental problems. In this work our research 
team, develops a method for clean production Figure 1. 
In all cases known volumes of water were diminish until the mini-
mum volume limit consumed. Distillation was use as physical method 
for water recovery, and we managed for reuse 45% of our residual 
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recovered water. Residual biomass where separated, centrifuged at 
8000rpm, and then by using a physical method for the obtention of 
residual bacterial cells (RBC) as described previously.21 
Table 1 show all media designed by based on King B commercial 
culture media. Designed media E1 to E4 shows all compounds added. 
Divalent Mg+2 and Ca+2 cations were added, seeking to provide a 
basic structure on which cross-linking is facilitated to obtain tridi-
mensional structure cellulose layers. It was previously established that 
biofilm architecture can also be strongly influenced by the interac-
tion of anionic extracellular polymeric substances (EPS), containing 
carboxylic groups, with multivalent cations. For example, Ca+2 can 
form a bridge between polyanionic molecules, stimulating the deve-
lopment of thick and compact biofilms with increased mechanical 
stability.32 NaCl was added seeking saline stress and increased pro-
duction of BNC. It is known that salt stress also biofilm formation 
and protects this mini assembly by retaining a water layer around the 
cells.33 However when BNC was measured as dry weigh of BNCg/L 
of culture media, mono and di valent salts did not increase production. 
Being in all cases, BNC lesser than reference media King B produc-
tions yield Figure 2A. Our results are in line with previous studies 
where exopolysaccharides production reduced in the medium with the 
addition of salt.34
Figure 2 shows BNC dry weight obtained by using media designed showed in table 1 and 2.
When King B was added whit carbon sources KB1 to KB4 were 
designed. In all cases production yield was improve in reference to 
commercial media (2.21±0.15 g/L). When carbon source added was 
glycerol (KB1) production yield increases 155.2 %. When carbon 
source added was glucose and glycerol (KB2) production yield was 
100.9% higher than reference medium. When glucose as carbon sour-
ces was added (KB3) production yield was 73.76 % higher than com-
mercial media. When consumed culture media, was added as carbon 
source (KB4) non-significant differences were found between KB1 
and KB4. This finding allows us to reduce even more residues in our 
own CP protocol and diminish cost with the mayor production of 
BNC.
Table 2 shows four media designed by using Luria Bertani culture 
media as commercial media control. Dry weight BNC production on 
LB maximum productivity was 2.07±0.18 g/L. Figure 2B shows all 
data obtain, in every case dry weight data was significantly different 
to control p<0.001.When glucose was added (L1) to LB commercial 
medium production yield was 211.6% being the mayor production 
of BNC from P. fluorecens presented on this paper. When residual 
bacterial cells were added to the culture media designed production 
increase over 96%. GS1 and GS4 can be a good replacement for car-
bon sources and its fount are strictly residues. This media are part 
on a national patent solicitude on the National Institute of Industrial 
Property NºAR20170123114 and our CP protocol.
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Figure 3 shows micrographs obtained by using SEM (Material and 
Methods point 6). BNC scanning electron microscopy is a noninva-
sive quality control alternative. When BNC derived from King’s B 
media was tested (A-F) the particles showed an arrangement in the 
form of aciculate crystals. When BNC derived from LB media was 
tested (G-I), the particles adopted flake format. In both cases the size 
of the BNC particles varies from 15μm to 30nm, arranged in a com-
plex, very compact reticulated structure. It should be noted that the 
thermal treatment used to dry the samples causes the compaction of 
the three-dimensional network of BNC as explained previously.23 Fi-
gure 4 shows the acicular crystals of cellulose obtained using the KB3 
medium. Gram staining with modified Congo red highlights the BNC 
crystals described in the Figure 3 G micrograph.
Figure 3 BNC Scan electron microscopy A) E1. B) E2. C) E3. D) E4. E) KB1. F) KB2. G) KB3. H) KB4. I) GS1. J) GS4. K) Amplified image from J. L) L1.
Figure 4 BNC Micrograph Congo red Tinction.
Quality control
Table 3 shows the main assignations described for cellulose found 
in the reference.35‒41 These bands were used for the subsequent analy-
sis of the obtained products. BNC spectra obtained from design media 
based on King B, showed an increase in the quality of the final pro-
ducts against BNC obtained from King B controls. The absorbance 
at the glycosidic region increases considerably for all spectra which 
could be caused by a higher polymerization degree (Figure 5). The 
spectra of E2, E4, KB1 and KB3 showed intense bands at ~450cm-1 
and ~860cm-1 (Figure 5 and Figure 6). This could be owed to the 
high crystallinity of these products.27,39 even above of the products 
obtained from commercial King B media. Conversely, E1, E3, KB2 
and KB4 presented amorphous characteristics, showed intense peaks 
at ~2900cm-1 and week bands at ~1450cm-1 39, 42 (Figure 5 and Fi-
gure 6). Cellulose formed in LB media was less cohesive than King 
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B products and was dispersed in the medium. However, better results 
were found analyzing the BNC spectra obtained from design media 
based on LB (Figure 7). Similar patterns to the reference were found 
in these spectra. Although BNC spectra from design media based on 
LB showed bands at ~1430cm-1 related to its crystallinity.27 (Figure 
7), an important band at 2900cm-1 was also observed, indicating that 
the BNC structure obtained from the design media had an amorphous 
structure compared to its analogues obtained from modified King B 
(Figure 7).28 In addition, the absorbance in the glycosidic region was 
very low, indicating the low polymerization degree and the low cohe-
siveness of these products (Figure 7). GS3 showed a low absorbance 
at 1650cm-1 respect to the rest of BNC from modified LB media. 
Figure 5 Spectra for BNC obtained from different design media based on 
King B added with salts. E1 and E3 showed amorphous characteristics, while 
E2 and E4 showed crystallinity properties.
Table 3 Main IR vibrational modes for cellulose. *2900 cm-1 is also known as 
“amorphous band”
Region (cm-1) Vibrational modes
3175-3500 O-H streching from itramolecular hydrogen bonds.
2850-2970* symetric and asymetric streching of >CH2 groups
1649 –1634 O–H bond streching of the water
1430-1420** >CH2 groups scissoring
1382-1375 C-H linkages
1336 O-H streching in the plane
1317 >CH2 wagging
∼1166 Band of C–C streching for rings
∼1116 Band of C–O–C eter glycosidic linkage
1058 C–O–C groups steching in pyranose rings
1034 C-O groups of C-OH linkage in carbohydrates
902 – 893 C-O-C deformation of the β(1-4) glycosidic linkage
**1430 cm-1 also known as the “crystalline band”, *2900 cm-1 is also known 
as “amorphous band”.
Figure 6 Spectra for BNC obtained from different design media based on 
King B added with carbon sources. KB2 and KB4 showed amorphous charac-
teristics, while KB1 and KB3 showed crystallinity properties.
Figure 7 Spectra for BNC obtained from different design media based on LB.
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Table 4 shows crystallinity index estimated from spectra. There 
was a total correlation with the bands found in the commercial cellu-
lose spectrum and the reference described. The spectra obtained for all 
BNC products presented similar spectral patterns to the observed in 
commercial cellulose. However, certain BNCs showed a crystallinity 
degree higher than the commercial sample taken as a reference, as 
could be observed in E1, E3 and L1 crystallinity index 1 and 2 (Table 
4).
Table 4 Crystallinity index estimated from FT IR spectra
Samples  CI1 CI2
Comercial BNC PH-101-LD 3,00 0,41















Figure 8, shows commercial samples and biotechnology produced 
samples, where compared by SEM technique as previously descri-
bed. The differences in appearance and degree of crystallinity pre-
viously discussed could be due to the extraction process used. When 
Kraft method was used.43 strong acids and bases were employed; this 
generates the “rag appearance”. It is clearly observed that the parti-
cles, on a micro scale, are folded on themselves. This process that 
generates the folding influences the physical properties attributed to 
the cellulose particles obtained. The geometric properties of the na-
nocellulose structures (shape, length and diameter) depend mainly on 
the extraction process and on the origin of the cellulose raw material.43 
While the photos obtained at the same magnification scale of BNC 
(20000X), obtained by a green method, the crystals are arranged in 
scales, they are needle-like as shown in Figure 4.4 The size at nano 
scale and its acicular composition and its arrangement in rosettes, they 
are related not only to the biotechnological process but also to the use 
of green solvents and diluted bases. These observations reinforce the 
findings and drive us to design pharmaceutical products to verify the 
difference in behavior of the same pure product, which was obtained 
by two different methods. KB3 was the designed media that complies 
with the prerogatives of maximum performance and high degree of 
crystallinity. Their aciculate crystals were shown in Figure 3 (J) and 
in Figure 4. Due to their characteristics, the BNC obtained using this 
culture medium was selected for the design of the coatings prototypes.
Figure 8 Shows SEMS images from commertial samples: PH101 and 
Comprecel compared to BNC.
Prototype development
Physical properties analysis: Solubility is defined as the content 
of dry matter solubilized after 24h immersion in water. Table 5 shows 
HPMC films physical properties. The higher solubility of the film is 
attributed to the water binding capacity. By replacing cellulose for 
BNC on the original formula, we seek to establish how its configu-
ration modifies the film behavior. F1 shows the lowest water binding 
capacity when it was compared to the control film and its water so-
lubility was significantly different from control formulation (CF). F2 
shows none significantly differences against control. Water solubility 
tests are determinant to establish the use of a prototype film. 
Table 5 FFS, film forming solution; CF, control formulation; BNC, bacterial nano cellulose; HPMC, hydroxy propyl methyl cellulose; MCC, microcrystalline 
cellulose; WS, water solubility 25°C; SP, swelling power; MC, moisture content; UV BC,: UV barrier Capacity
Samples /Composition (g)
Film preformulation studies
Physical properties Optical properties
FSS HPMC MCC BNC WS% SP% MC% Opacity UV/BC
F1 1.43 0.04 0.04 92.52 ± 0.34*** 36.43±1.51** .44±0.41** 28.96±0.95* 90.66±0.52***
F2 1.43 0 0.08 95.02±1.65* 34.25±0.33*** 4.68±0.03*** 27.41±0.52* 95.11±1.71***
CF 1.43 0.08 0 98.96±1.48 42.42±2.06 6.36±0.22 27.82±0.37 52.96±0.43
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Control film is made completely by using cellulose and deriva-
tives from vegetal origin. As the fiber swells, intermolecular bonds 
are broken as a result of the internal stresses produced. The degree 
of order within the fiber is reduced and there is an increase in the 
surface area of the fiber.44 BNC has a different structure that influen-
ce on swelling power. When BNC films swelling power was tested 
significantly differences against control was found. F2 who has high 
proportion of BNC shows lesser swelling power (p<0.001). Robert-
son.45 suggested that the factors that determine the effectiveness of the 
swelling liquid in cellulose include the hydrogen bonding properties 
and the existence of intermolecular forces that are summed up in the 
cohesive energy density. In addition, other factors such as molecular 
volume and steric effects are also of importance. The interaction with 
cellulose fibers depends additionally on the structure and porosity of 
the fiber. Moisture content is a measure of empty volume in the micro 
reticulates susceptible to being occupied by water molecules.46 When 
F1 Y F2 were tested, moisture content was significantly different 
against control showing that films of vegetal cellulose are more water 
soluble, presents mayor swelling power and moisture content. These 
results shows that films designed entirely with vegetal origin cellulose 
are ideal for food products films such as coatings for fruits, which can 
be ingested with it. BNC increases properties such as lower solubility 
in water values, less swelling power and less moisture content, these 
are desirable when the application of the films is for the manufacture 
in controlled release patches design. It is also a measure of biodegra-
dability of the films these property is useful for biodegradable packa-
ging. BNC present an additional advantage, having lower UV permea-
bility than films with cellulose of vegetal origin. Adds this potentiality 
in a patch design that protects the injured stratum, protecting the site 
from the wound and replacing the skin in its barrier function since the 
broken skin has lost its UV barrier action protecting the tissue. It also 
blocks UV light and protects Active Pharmaceutical Ingredients. On 
the other hand, these films are useful for the manufacture of containers 
for example to store vegetable or seed oils since they contain variable 
levels of unsaturated olefin acids that are susceptible to degradation 
by light. The incorporation of a low percentage BNC significantly re-
duces the transmission of UV light to the interior of the container and 
preserves the packaged product for longer.
Conclusion
Media designed allow as obtaining industrial interest products, 
exacerbating useful cellulose polymers properties. For both modified 
LB and modified King B, BNC obtained had better quality respect 
to its crystallinity and/or polymerization degree than the BNC from 
commercial media. The heterogeneity in the BNC properties found 
in this work allows designing procurement methods according to the 
final purpose of the desired product. In no case had remnants of mi-
crobiological material been found. For all cases, the BNC showed a 
crystallinity structure greater than the commercial cellulose. This cha-
racterization method could be used in the future for the quality control 
of the products in the production line. The prototypes of films obtai-
ned have advantages over those designed using cellulose of vegetable 
origin. The characteristics of the designed films significantly extend 
the applications of this type of topical pharmaceutical form.
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